125 results
8-K
EX-1.1
0cj nriwp
2 Apr 24
Entry into a Material Definitive Agreement
5:10pm
424B5
eyiesz6l5533
2 Apr 24
Prospectus supplement for primary offering
4:58pm
8-K
EX-99.1
kt48o2sms 7rrjextf
25 Mar 24
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
8-K
EX-99.1
qs1symh263ql9dkh7f
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
UPLOAD
dl734d
16 Nov 23
Letter from SEC
12:00am